UK biotech iFAST Diagnostics has closed a £5 million funding round. iFAST is addressing the $4 billion (and growing) Antimicrobial Susceptibility Testing (AST) market. It has developed a test deliveri...
UK biotech iFAST Diagnostics has closed a £5 million funding round. iFAST is addressing the $4 billion (and growing) Antimicrobial Susceptibility Testing (AST) market. It has developed a test deliveri...
Source: Tech.eu — read the full report at the original publisher.
This is a curated wire item. The Continuum Brief does not republish full third-party articles; this entry links to the original source.
